Fertility and Sterility
Volume 94, Issue 5 , Pages 1769-1774 , October 2010

A prospective evaluation of antral follicle function in women with 46,XX spontaneous primary ovarian insufficiency

  • Ziad R. Hubayter, M.D., M.P.H.

      Affiliations

    • Integrative Reproductive Medicine Unit, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland
    • ,
  • Vaishali Popat, M.D., M.P.H.

      Affiliations

    • Integrative Reproductive Medicine Unit, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland
    • ,
  • Vien H. Vanderhoof, R.N., M.H.A., C.R.N.P.

      Affiliations

    • Integrative Reproductive Medicine Unit, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland
    • ,
  • Obioma Ndubizu, M.D.

      Affiliations

    • Integrative Reproductive Medicine Unit, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland
    • ,
  • Diane Johnson, R.T., R.D.M.S.

      Affiliations

    • Clinical Center, National Institutes of Health, Bethesda, Maryland
    • ,
  • Edie Mao, M.B., R.D.M.S., R.V.T.

      Affiliations

    • Clinical Center, National Institutes of Health, Bethesda, Maryland
    • ,
  • Karim A. Calis, Pharm.D., M.P.H.

      Affiliations

    • Clinical Center, National Institutes of Health, Bethesda, Maryland
    • ,
  • James F. Troendle, Ph.D.

      Affiliations

    • Biostatistics and Bioinformatics Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland
    • ,
  • Lawrence M. Nelson, M.D.

      Affiliations

    • Integrative Reproductive Medicine Unit, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland
    • Corresponding Author InformationReprint requests: Lawrence M. Nelson, M.D., National Institutes of Health, CRC 1-3330, 10 Center Drive, MSC-1103, Bethesda, MD 20892-1103 (FAX: 301-402-0884).

Received 26 February 2009 ,Revised 13 October 2009 ,Accepted 13 October 2009.

References 

  1. Mattison DR, Thomford PJ, Jelovsek FR. Disposition of oocytes and age at menopause. N Engl J Med. 1988;318:644
  2. Baker TG. A quantitative and cytological study of germ cells in the human ovaries. Proc R Soc Lond B Biol Sci. 1963;158:417–433
  3. Albright F, Smith PH, Fraser R. A syndrome characterized by primary ovarian insufficiency and decreased stature. Am J Med Sci. 1942;204:625–648
  4. van Kasteren YM, Schoemaker J. Premature ovarian failure: a systematic review on therapeutic interventions to restore ovarian function and achieve pregnancy. Hum Reprod Update. 1999;5:483–492
  5. Welt CK. Primary ovarian insufficiency: a more accurate term for premature ovarian failure. Clin Endocrinol (Oxf). 2008;68:499–509
  6. Nelson LM. Primary ovarian insufficiency. N Engl J Med. 2009;360:606–614
  7. Coulam CB. Premature gonadal failure. Fertil Steril. 1982;38:645–655
  8. Rebar RW, Erickson GF, Yen SSC. Idiopathic premature ovarian failure: clinical and endocrine characteristics. Fertil Steril. 1982;37:35–41
  9. Rebar RW, Connolly HV. Clinical features of young women with hypergonadotropic amenorrhea. Fertil Steril. 1990;53:804–810
  10. Nelson LM, Anasti JN, Kimzey LM, Defensor RA, Lipetz KJ, White BJ, et al. Development of luteinized Graafian follicles in patients with karyotypically normal spontaneous premature ovarian failure. J Clin Endocrinol Metab. 1994;79:1470–1475
  11. Conway GS, Kaltsas G, Patel A, Davies MC, Jacobs HS. Characterization of idiopathic premature ovarian failure. Fertil Steril. 1996;65:337–341
  12. Taylor AE, Adams JM, Mulder JE, Martin KA, Sluss PM, Crowley WFJ. A randomized, controlled trial of estradiol replacement therapy in women with hypergonadotropic amenorrhea. J Clin Endocrinol Metab. 1996;81:3615–3621
  13. McNatty KP, Makris A, Reinhold VN, De GC, Osathanondh R, Ryan KJ. Metabolism of androstenedione by human ovarian tissues in vitro with particular reference to reductase and aromatase activity. Steroids. 1979;34:429–443
  14. Sasano H, Okamoto M, Mason JI, Simpson ER, Mendelson CR, Sasano N, et al. Immunolocalization of aromatase, 17 alpha-hydroxylase and side-chain-cleavage cytochromes P-450 in the human ovary. J Reprod Fertil. 1989;85:163–169
  15. Guidelines for remuneration of research subjects in the Intramural Research Program. Bethesda, MD: office of Human Subjects Research, National Institutes of Health, 2-9-2009, 7-16-2009.
  16. Pastor CL, Vanderhoof VH, Lim LC, Calis KA, Premkumar A, Guerrero NT, et al. Pilot study investigating the age-related decline in ovarian function of regularly menstruating normal women. Fertil Steril. 2005;84:1462–1469
  17. Fanchin R, de Ziegler D, Olivennes F, Taieb J, Dzik A, Frydman R. Exogenous follicle stimulating hormone ovarian reserve test (EFORT): a simple and reliable screening test for detecting “poor responders” in in-vitro fertilization. Hum Reprod. 1994;9:1607–1611
  18. Box GEP, Cox DR. An analysis of transformations. J R Stat Soc Series B. 1964;26:211–252
  19. Ryan KJ, Petro Z. Steroid biosynthesis by human ovarian granulosa and thecal cells. J Clin Endocrinol Metab. 1966;26:46–52
  20. Westergaard L, Christensen IJ, McNatty KP. Steroid levels in ovarian follicular fluid related to follicle size and health status during the normal menstrual cycle in women. Hum Reprod. 1986;1:227–232
  21. van Santbrink EJ, Hop WC, van Dessel TJ, de Jong FH, Fauser BC. Decremental follicle-stimulating hormone and dominant follicle development during the normal menstrual cycle. Fertil Steril. 1995;64:37–43
  22. van Dessel HJ, Schipper I, Pache TD, van Geldorp H, de Jong FH, Fauser BC. Normal human follicle development: an evaluation of correlations with oestradiol, androstenedione and progesterone levels in individual follicles. Clin Endocrinol. 1996;44:191–198
  23. Check JH, Nowroozi K, Chase JS, Nazari A, Shapse D, Vaze M. Ovulation induction and pregnancies in 100 consecutive women with hypergonadotropic amenorrhea. Fertil Steril. 1990;53:811–816
  24. Santoro N. Mechanisms of premature ovarian failure. Ann Endocrinol (Paris). 2003;64:87–92
  25. LaPolt PS, Jia XC, Sincich C, Hsueh AJ. Ligand-induced down-regulation of testicular and ovarian luteinizing hormone (LH) receptors is preceded by tissue-specific inhibition of alternatively processed LH receptor transcripts. Mol Endocrinol. 1991;5:397–403
  26. Rabin D, Spitz I, Bercovici B, Bell J, Laufer A, Benveniste R, et al. Isolated deficiency of follicle-stimulating hormone: clinical and laboratory features. N Engl J Med. 1972;287:1313–1317
  27. Layman LC, Lee EJ, Peak DB, Namnoum AB, Vu KV, van Lingen BL, et al. Delayed puberty and hypogonadism caused by mutations in the follicle-stimulating hormone beta-subunit gene. N Engl J Med. 1997;337:607–611
  28. Kumar TR, Wang Y, Lu N, Matzuk MM. Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility. Nat Genet. 1997;15:201–204
  29. Aittomaki K, Herva R, Stenman UH, Juntunen K, Ylostalo P, Hovatta O, et al. Clinical features of primary ovarian failure caused by a point mutation in the follicle-stimulating hormone receptor gene. J Clin Endocrinol Metab. 1996;81:3722–3726
  30. Sherman BM, Korenman SG. Hormonal characteristics of the human menstrual cycle throughout reproductive life. J Clin Invest. 1975;55:699–706
  31. Yong EL, Baird DT, Yates R, Reichert LE, Hillier SG. Hormonal regulation of the growth and steroidogenic function of human granulosa cells. J Clin Endocrinol Metab. 1992;74:842–849
  32. Doody KJ, Lorence MC, Mason JI, Simpson ER. Expression of messenger ribonucleic acid species encoding steroidogenic enzymes in human follicles and corpora lutea throughout the menstrual cycle. J Clin Endocrinol Metab. 1990;70:1041–1045
  33. Surrey ES, Cedars MI. The effect of gonadotropin suppression on the induction of ovulation in premature ovarian failure patients. Fertil Steril. 1989;52:36–41
  34. Nelson LM, Kimzey LM, White BJ, Merriam GR. Gonadotropin suppression for the treatment of karyotypically normal spontaneous premature ovarian failure: a controlled trial. Fertil Steril. 1992;57:50–55
  35. Morris RS, Sauer MV. New advances in the treatment of infertility in women with ovarian failure. Curr Opin Obstet Gynecol. 1993;5:368–377
  36. Anasti JN, Kimzey LM, Defensor RA, White B, Nelson LM. A controlled study of danazol for the treatment of karyotypically normal spontaneous premature ovarian failure. Fertil Steril. 1994;62:726–730
  37. van Kasteren YM, Hoek A, Schoemaker J. Ovulation induction in premature ovarian failure: a placebo-controlled randomized trial combining pituitary suppression with gonadotropin stimulation. Fertil Steril. 1995;64:273–278
  38. Popat VB, Vanderhoof VH, Calis KA, Troendle JF, Nelson LM. Normalization of serum luteinizing hormone levels in women with 46, XX spontaneous primary ovarian insufficiency. Fertil Steril. 2008;89:429–433
  39. Lacker HM, Ethan A. How do the ovaries count?. Math Biosci. 1988;90:305–332
  40. Duncan M, Cummings L, Chada K. Germ cell deficient (gcd) mouse as a model of premature ovarian failure. Biol Reprod. 1993;49:221–227

 Z.R.H. had nothing to disclose. V.P. has nothing to disclose. V.H.V. has nothing to disclose. O.N. has nothing to disclose. D.J. has nothing to disclose. E.M. has nothing to disclose. K.A.C. has nothing to disclose. J.F.T. has nothing to disclose. L.M.N. has nothing to disclose.

 Supported by the Intramural Research Program of the National Institute of Child Health and Human Development, National Institutes of Health. Vien H. Vanderhoof and Lawrence M. Nelson are Commissioned Officers in the United States Public Health Service.

PII: S0015-0282(09)03885-0

doi: 10.1016/j.fertnstert.2009.10.023

Fertility and Sterility
Volume 94, Issue 5 , Pages 1769-1774 , October 2010

Article Tools

* Image Usage & Resolution